AnaptysBio
AnaptysBio manages biopharmaceutical royalty collaborations for Jemperli with GSK and imsidolimab with Vanda, following the 2026 spin-off of its drug-development business into First Tracks Biotherapeutics.
Key facts
| CAGE Code | 583E4 |
|---|---|
| Legal Name | AnaptysBio, Inc. |
| Company Operating Status | Active |
| Full Address | 10770 Wateridge Circle Suite 210 San Diego, CA 92121-5801 |
| Previous Name | ANAPTYS BIOSCIENCES INC |
| Public/Private | Public |
| Stock Symbol | ANAB |
| Ticker Symbol | ANAB |
| Wellfound ID | anaptysbio |
Contact details
Email and phone for AnaptysBio are available to signed-in members of CliffBio.
Sign in to view